As the global pandemic continues, we find ourselves in the midst of a medical device and equipment shortage. The shortage has compelled medical providers to invest heavily in alternative sterile medical products and, in some instances, to implement rationing.
Amidst these already tense dynamics, the FDA has requested that the EPA pump the brakes on new EtO rules, proposed regulations that impact the sterilization process for a range of medical supplies.
Full details on the situation were published by law firm Goldberg Segalla on JD Supra.
Ethylene oxide (EtO) is a gas commonly used for sterilizing heat-sensitive medical devices. However, the EPA has been looking to enforce stricter regulations amid growing health and environmental concerns associated with the gas. The FDA, recognizing the precarious nature of the current medical device supply chain, has counseled caution.
It is crucial that all parties involved tread carefully. Managing the health risks associated with EtO use, while ensuring supply-chain stability in a pandemic-wracked world, presents a unique and demanding challenge for the EPA, FDA, and the healthcare industry at large.